ID1 and glioblastoma: In contrast, high ROS levels in othertumors inhibited CBD-induced hGSC death, making ROS a predictive markerfor CBD responsiveness. The transcriptionalregulator Id-1 is present in GBM cell lines and primary cultures,and its expression is associated with heightened invasiveness.